• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Life Sciences | News, Analysis, Insights - HIT Consultant

AiCure Launches Platform to Remotely Capture Digital Biomarkers in Clinical Trials

by Fred Pennic 04/28/2020 Leave a Comment

AiCure Launches Platform to Remotely Capture Digital Biomarkers in Clinical Trials

What You Should Know: - AiCure launches digital biomarker platform to remotely detect subtle changes in a patient's condition, leverages computer vision and AI to gather and analyze visual and auditory cues directly through the patient's smartphone camera. - AiCure appoints Ed Ikeguchi, M.D. as its Chief Executive Officer (CEO) to advance AiCure's commitment to improving holistic health through an understanding of the science behind human responses to illness and treatment. AiCure,
Read More

Airforce to Deploy FDA-Approved Oral Fluid COVID-19 Tests Across US Military

by Fred Pennic 04/23/2020 Leave a Comment

Airforce to Deploy FDA-Approved Oral Fluid COVID-19 Tests Across US Military

What You Should Know: COVID-19 testing startup Curative Inc. and Gothams announced it has signed an agreement (phase one is $13m USD) with the U.S. Air Force to deploy its FDA-authorized oral fluid COVID-19 tests and comprehensive testing service to U.S. military personnel around the world.  In this initial agreement, Curative will rapidly establish a new laboratory facility, fully operational this week, which will process
Read More

Central, Searchable Repository for all COVID-19 Clinical Trials Launches

by Fred Pennic 04/14/2020 Leave a Comment

Central, Searchable Repository for all COVID-19 Clinical Trials Launches

What You Need to Know: - Inato unveils central, searchable repository for all COVID-19 clinical trials designed to support clinical researchers, physicians, and biopharma organizations. - By centralizing all clinical studies being conducted worldwide and updating trial trends with new information from public registries and aggregators daily, Inato seeks to optimize COVID-19 clinical trial resource allocation and help address any unmet needs as quickly as possible.  Paris-based (and
Read More

IntegriChain Acquires Cumberland’s Life Sciences Division

by Fred Pennic 04/14/2020 Leave a Comment

IntegriChain Acquires Cumberland’s Life Sciences Division

What You Should Know: - IntegriChain acquires Cumberland’s Life Sciences division to create life sciences' only comprehensive data and business process platform for market access and commercialization. - Together, the analytics, applications, managed services and expert advisory services powers 220+ Life Sciences manufacturers' operations and harness the value of their channel, patient and payer data. IntegriChain, a leading Life Sciences data, and managed services company that
Read More

Medtronic Awarded Emergency Authorization for Compact Ventilator to Support COVID-19 Patients

by Fred Pennic 04/09/2020 Leave a Comment

Medtronic Awarded Emergency Authorization for Compact, Portable Ventilator in the U.S.

What You Should Know: - The company received authorization from the U.S. Food and Drug Administration (FDA) to offer the PB560 ventilator in the U.S. through the agency’s Emergency Use Authorization (EUA) authority. - Lightweight and compact, the Puritan Bennett™ 560 portable ventilator helps enable patients to live with greater independence while providing caregivers with the peace of mind that comes with a reliable and trusted ventilation system with long battery life. Medtronic
Read More

Exscientia to Screen 15,000 Drugs in Search for Coronavirus Treatment

by Jasmine Pennic 04/07/2020 Leave a Comment

Exscientia to Screen 15,000 Drugs in Search for Coronavirus Treatment

What You Should Know: - Exscientia announced a joint transatlantic initiative with Diamond Light Source, the UK's national synchrotron facility and Calibr, a division of Scripps Research (USA), to screen nearly every known approved and investigational drug against key COVID-19 drug targets to progress compounds that could rapidly become viable drugs for the rapid treatment of the coronavirus. - Exscientia has gained access to Calibr’s world’s leading collection of 15,000 clinically-ready
Read More

Analysis: Applying AI in the Fight Against The Coronavirus

by Dr. Ulrik Kristensen, Senior Market Analyst at Signify Research 04/01/2020 Leave a Comment

The Many Faces of AI in Clinical Trials

Drug discovery is a notoriously long, complex and expensive process requiring the concerted efforts of the world’s brightest minds. The complexity in understanding human physiology and molecular mechanisms is increasing with every new research paper published and for every new compound tested. As the world is facing a new challenge in trying to both adapt to and defend itself against the coronavirus, artificial intelligence is offering new hope that a cure might be developed faster than ever
Read More

COVID-19 Treatment and Vaccine Tracker Identifies New Treatments & Vaccines in Development

by Jasmine Pennic 03/30/2020 Leave a Comment

COVID-19 Treatment and Vaccine Tracker Identifies New Treatments & Vaccines in Development

What You Should Know: - The Milken Institute launched an effort to track and disseminate accurate information about COVID-19 treatments and vaccines in development. - Since launch, more than two dozen new candidates have been identified, with some progressing toward clinical trials. The Milken Institute COVID-19 Treatment and Vaccine Tracker has identified 16 new treatments in the pipeline along with nine new vaccine candidates since
Read More

AstraZeneca Selects BrightInsight’s IoT Platform to Focus on Chronic Disease Management

by Jasmine Pennic 03/25/2020 Leave a Comment

AstraZeneca Selects BrightInsight’s IoT Platform to Focus on Chronic Disease Management

What You Should Know: - AstraZeneca selects the BrightInsight Platform to build and manage its digital health solutions within a regulatory-compliant environment  - Digital health represents a major opportunity to alleviate some of the biggest concerns in healthcare today—many of which are being amplified due to COVID 19—including the length and cost of clinical trials, better remote testing, and tracking of patients, access to data and delivery of care.  - AstraZeneca and others are
Read More

Wolters Kluwer, SAS Integrate to Power Real-World Evidence (RWE) Analytics

by Jasmine Pennic 03/03/2020 Leave a Comment

Wolters Kluwer, SAS Integrate to Power Real-World Evidence (RWE) Analytics

- SAS to leverage Wolters Kluwer’s Health Language portfolio of data quality solutions to power real-world evidence (RWE) analytics within SAS Health. - Through a disease-centric approach, Health Language will enable SAS Health’s clients to more effectively manage reference data, such as ICD-10, CPT® and SNOMED CT, establish relationships between clinical and claims data and extract value from unstructured text within the medical record–providing a comprehensive view of a patient’s clinical
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 79
  • Go to page 80
  • Go to page 81
  • Go to page 82
  • Go to page 83
  • Interim pages omitted …
  • Go to page 86
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |